107 related articles for article (PubMed ID: 21370250)
21. Determination and characterization of degradation products of anastrozole by LC-MS/MS and NMR spectroscopy.
Sitaram C; Rupakula R; Reddy BN
J Pharm Biomed Anal; 2011 Dec; 56(5):962-8. PubMed ID: 21890298
[TBL] [Abstract][Full Text] [Related]
22. A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Ibrutinib Using QbD Approach by RP-HPLC, NMR Spectroscopy and ESI-MS.
Gopireddy RR; Maruthapillai A; Mahapatra S
J Chromatogr Sci; 2021 Sep; 59(9):830-846. PubMed ID: 33420506
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation products.
Ragham PK; Chandrasekhar KB
J Pharm Biomed Anal; 2016 Jun; 125():122-9. PubMed ID: 27018505
[TBL] [Abstract][Full Text] [Related]
24. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
[TBL] [Abstract][Full Text] [Related]
25. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
26. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
Nageswara Rao R; Narasa Raju A; Narsimha R
J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
Kasawar GB; Farooqui M
J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
[TBL] [Abstract][Full Text] [Related]
29. LC-MS/MS method for the characterization of the forced degradation products of Entecavir.
Ramesh T; Rao PN; Rao RN
J Sep Sci; 2014 Feb; 37(4):368-75. PubMed ID: 24323372
[TBL] [Abstract][Full Text] [Related]
30. Study of forced degradation behaviour of florfenicol by LC and LC-MS and development of a validated stability-indicating assay method.
Mistiri F; Louati K; Grissa O; Kallel M; Safta F
Ann Pharm Fr; 2012 Nov; 70(6):333-47. PubMed ID: 23177560
[TBL] [Abstract][Full Text] [Related]
31. RP-HPLC separation and characterization of unknown impurities of a novel HIV-protease inhibitor Darunavir by ESI-MS and 2D NMR spectroscopy.
Nageswara Rao R; Ramachandra B; Santhakumar K
J Pharm Biomed Anal; 2013 Mar; 75():186-91. PubMed ID: 23266664
[TBL] [Abstract][Full Text] [Related]
32. LC-MS/MS characterization of forced degradation products of zofenopril.
Ramesh T; Nageswara Rao P; Nageswara Rao R
J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
[TBL] [Abstract][Full Text] [Related]
33. LC-MS/MS structural characterization of stress degradation products including the development of a stability indicating assay of Darunavir: An anti-HIV drug.
Rao RN; Ramachandra B; Sravan B; Khalid S
J Pharm Biomed Anal; 2014 Feb; 89():28-33. PubMed ID: 24252722
[TBL] [Abstract][Full Text] [Related]
34. HPLC method for the determination of emtricitabine and related degradation substances.
Hamarapurkar PD; Parate AN
J Chromatogr Sci; 2013; 51(5):419-24. PubMed ID: 23051064
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
Reddy PS; Sudhakar Babu K; Kumar N
J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
[TBL] [Abstract][Full Text] [Related]
36. Reverse phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma.
Rote AR; Pingle SP
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3719-23. PubMed ID: 19716354
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
[TBL] [Abstract][Full Text] [Related]
38. Development of a Forced Degradation Profile of Alosetron by Single Mode Reversed-Phase HPLC, LC-MS, and its Validation.
Karthik Y; Babu B; Meyyanathan SN
Sci Pharm; 2015; 83(2):311-20. PubMed ID: 26839817
[TBL] [Abstract][Full Text] [Related]
39. Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Anagrelide Hydrochloride.
Pujeri SS; Khader AM; Seetharamappa J
Sci Pharm; 2012; 80(3):567-79. PubMed ID: 23008806
[TBL] [Abstract][Full Text] [Related]
40. Identification and Characterization of an Oxidative Degradation Product of Fexofenadine, Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Process Related Impurities and Degradation Products of Fexofenadine in Pharmaceutical Formulations.
Vaghela B; Rao SS; Reddy AM; Venkatesh P; Kumar N
Sci Pharm; 2012; 80(2):295-309. PubMed ID: 22896817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
